Investment Management Corp of Ontario (IMCO)’s West Pharmaceutical WST Stock Holding History

Investment Management Corp of Ontario (IMCO)’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.66M	Sell	4,622 -520	-10%	-$159K	0.02%	463
2026 Q1	$1.29M	Sell	5,142 -1,407	-21%	-$350K	0.02%	520
2025 Q4	$1.8M	Buy	6,549 +3,165	+94%	+$866K	0.02%	454
2025 Q3	$888K	Buy	3,384 +1,604	+90%	+$390K	0.01%	504
2025 Q2	$389K	Sell	1,780 -300	-14%	-$64.1K	0.01%	563
2025 Q1	$466K	Buy	+2,080	New	+$573K	0.01%	545
2024 Q4	–	Sell	-2,380	Closed	-$714K	–	666
2024 Q3	$714K	Sell	2,380 -1,636	-41%	-$501K	0.02%	459
2024 Q2	$1.32M	Buy	4,016 +500	+14%	+$177K	0.04%	284
2024 Q1	$1.39M	Sell	3,516 -500	-12%	-$185K	0.04%	254
2023 Q4	$1.41M	Buy	4,016 +1,680	+72%	+$595K	0.03%	292
2023 Q3	$876K	Buy	+2,336	New	+$903K	0.03%	186

Other funds holding WST

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Investment Management Corp of Ontario (IMCO)'s WST Position: Q2 2026 in Review

Investment Management Corp of Ontario (IMCO) reduced its West Pharmaceutical (WST) stake by 10% in Q2 2026, selling an estimated $159K and leaving 4,622 shares worth $1.66M. The position accounts for 0.02% of the portfolio, ranked #463.

Investment Management Corp of Ontario (IMCO) first reported a position in WST in Q3 2023 and has held it in 11 quarters since. The position peaked at $1.8M in Q4 2025. 833 funds tracked by Wall St. Rank hold WST as of Q2 2026.

Investment Management Corp of Ontario (IMCO) held 4,622 shares of West Pharmaceutical worth $1.66M as of Q2 2026.
Investment Management Corp of Ontario (IMCO) sold 520 West Pharmaceutical shares in Q2 2026, an estimated $159K.
West Pharmaceutical made up 0.02% of Investment Management Corp of Ontario (IMCO)'s portfolio in Q2 2026, its #463 holding.
Investment Management Corp of Ontario (IMCO) first reported a position in West Pharmaceutical in Q3 2023 and has held it in 11 quarters since.
Investment Management Corp of Ontario (IMCO)'s West Pharmaceutical position peaked at $1.8M in Q4 2025.
833 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Investment Management Corp of Ontario (IMCO)'s 13F filing for Q2 2026, filed 14 Aug 2026.